Universe Pharmaceuticals INC (NASDAQ:UPC) Stock Short Interest Report for September

Universe Pharmaceuticals INC (NASDAQ:UPC) was the recipient of a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 43,865 shares, a decline of 42.2% from the September 15th total of 75,844 shares. Currently, 2.0% of the company’s shares are short sold. Based on an average daily volume of 40,506 shares, the short-interest ratio is currently 1.1 days.

Wall Street Analyst Weigh In

UPC has been the subject of a number of research analyst reports. Weiss Ratings raised Universe Pharmaceuticals from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 29th. Wall Street Zen raised Universe Pharmaceuticals to a “hold” rating in a research report on Saturday, August 29th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Universe Pharmaceuticals Stock Performance

NASDAQ UPC traded up $0.06 during midday trading on Thursday, hitting $4.21. 2,855 shares of the company traded hands, compared to its average volume of 707,321. The company has a quick ratio of 3.90, a current ratio of 4.05 and a debt-to-equity ratio of 0.04. The company’s 50-day simple moving average is $4.82 and its 200-day simple moving average is $4.07. Universe Pharmaceuticals has a 52 week low of $2.00 and a 52 week high of $17.96.

Universe Pharmaceuticals (NASDAQ:UPC) last released its quarterly earnings results on Wednesday, July 29th. The company reported ($1.38) EPS for the quarter. The firm had revenue of $4.52 million during the quarter.

About Universe Pharmaceuticals

Universe Pharmaceuticals Inc (NASDAQ: UPC) is a China-based pharmaceutical company engaged in the development, manufacture and sale of traditional Chinese medicine (TCM) products and other healthcare offerings. The company serves consumers primarily through pharmaceutical distributors, retail pharmacies and other sales channels in China.

Universe Pharmaceuticals’ product portfolio includes over-the-counter and prescription pharmaceutical products, as well as healthcare and nutritional products.